It is past time for FDA to take action to terminate the ongoing deception and exploitation of consumers by corporations that use such misleading labels in their marketing campaigns. Enforcement action is clearly overdue.
Agricultural Biotech
April 13, 2020
Special interest groups blame intensive agriculture, GMOS, & pesticides for emergent disease and say the solution is low yielding organic farming. The truth is opposite.
November 15, 2019
The Non-GMO Project label is now misleading consumers on more than 60,000 food items in U.S. grocery stores. Val Giddings tells the Food & Drug Law Institute it's time for FDA to enforce the law and puit an end to this illegal practice.
November 12, 2019
It is past time for FDA to take action to terminate the ongoing deception and exploitation of consumers by corporations that use such misleading labels in their marketing campaigns. Enforcement action is clearly overdue.
September 24, 2019
Val Giddings' presentation to the Breakthrough Institute at Ecomodernism 2019 explores research to improve the efficiency of photosynthesis and what this means for climate mitigation and the global economy.
August 5, 2019
ITIF provided comments on USDA’s latest proposal to revise and update regulations for crops improved through biotechnology including gene editing.
June 14, 2019
The Indian Government has lagged in approving safe biotech improved crops for years while farmers around the world have been reaping the rewards. Indian farmers are "not gonna take it anymore..."
April 8, 2019
Scott Gottlieb has stepped down as FDA Commissioner. Val Giddings evaluates his legacy for the Innovation Files.
April 5, 2019
Val Giddings examines the recent jury verdicts for plaintiffs claiming their cancers were caused by the world's most widely used weedkiller, glyphosate. Scientists and regulators around the world claim it's safe - why have these juries disagreed?
March 21, 2019
In this briefing for congressional staff, Val Giddings introduces the topic of editing genes and genomes, touches on applications in both agriculture (animals and plants) and biomedicine, and then explores some of the far reaching policy implications.
March 14, 2019
Val Giddings' presentation on a panel at the Society for Benefit Cost Analysis meeting argues that regulatory disincentives to innovation in agricultural biotechnology can be reduced by a return to fundamental principals of risk assessment and management, as longstanding U.S. Policy requires.